Detalles de la búsqueda
1.
Is Telemedicine Suitable for Patients with Chronic Inflammatory Skin Conditions? A Systematic Review.
Acta Derm Venereol
; 104: adv23901, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38751176
2.
Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks.
Acta Derm Venereol
; 103: adv17752, 2023 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37877618
3.
Development of a New Referral Tool to Identify Psoriasis Patients with Concomitant Psoriatic Arthritis: Results of the Prospective DAPPER Cohort.
Acta Derm Venereol
; 103: adv5269, 2023 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37186169
4.
Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial.
J Eur Acad Dermatol Venereol
; 37(9): 1815-1824, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37014287
5.
Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center.
Acta Derm Venereol
; 102: adv00648, 2022 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35088874
6.
Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort.
Acta Derm Venereol
; 102: adv00768, 2022 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35818734
7.
Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort.
Acta Derm Venereol
; 102: adv00712, 2022 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35356990
8.
Immunomodulatory aged neutrophils are augmented in blood and skin of psoriasis patients.
J Allergy Clin Immunol
; 148(4): 1030-1040, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33745888
9.
Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients.
Pediatr Allergy Immunol
; 32(4): 720-726, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33305439
10.
Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice.
Acta Derm Venereol
; 101(5): adv00463, 2021 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903920
11.
Blood-Based Immune Profiling Combined with Machine Learning Discriminates Psoriatic Arthritis from Psoriasis Patients.
Int J Mol Sci
; 22(20)2021 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34681660
12.
Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study.
Acta Derm Venereol
; 100(19): adv00340, 2020 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33196101
13.
Prevalence of chronic urticaria and healthcare usage of patients with the condition in primary care: a population-based study in the Netherlands.
Br J Dermatol
; 190(2): 287-289, 2024 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897501
14.
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.
J Am Acad Dermatol
; 90(2): 395-397, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37804933
15.
Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study.
Acta Derm Venereol
; 99(4): 386-392, 2019 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30543381
16.
Should we prefer biologics over nonbiological agents in psoriasis?
Br J Dermatol
; 189(3): 258-259, 2023 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37421659
17.
How to define a 'super-responder' to biologics in psoriasis studies.
Br J Dermatol
; 189(5): 621-622, 2023 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37595133
18.
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study.
Acta Derm Venereol
; 98(7): 648-654, 2018 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29405245
19.
Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab.
Br J Dermatol
; 187(6): 1028-1030, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35895852
20.
Real-world Data Reveal Long Drug Survival for Guselkumab in Patients with Plaque Psoriasis.
Acta Derm Venereol
; 102: adv00755, 2022 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788690